City

Chelyabinsk (1)

Kawasaki City (1)

Kazan (1)

Novosibirsk (1)

Oryol (1)

Perm (1)

Samara (1)

St. Petersburg (1)

Stavropol (1)

Condition

Chronic Hepatitis C (CHC) (2)

Overall Status

Completed (2)

Sign in for free

Phase

phase 3 (1)

Sponsor

AbbVie (1)

Mitsubishi Tanabe Pharma Corporation (1)

Collaborator

Intervention

mp-424 (1)

peg-ifn alfa-2a (1)

rbv (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (2)

Study Type

Interventional (1)

Observational (1)

chronic hepatitis c (chc)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Clinical Practice Use of Glecaprevir Plus Pibrentasvir in

Completed

Chronic Hepatitis C (CHC)

Samara, Samarskaya Oblast, Russian Federation
+8 more

Aug 25, 2021

Chronic Hepatitis C (CHC) Trial in Kawasaki City (MP-424, RBV, PEG-IFN alfa-2a)

Completed

Chronic Hepatitis C (CHC)

MP-424
+2 more

Kawasaki City, Takatsu-ku, Japan

Toranomon Hospital

Aug 9, 2016